Concepedia

Publication | Open Access

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma

46

Citations

24

References

2003

Year

Abstract

GC administered according to a 3-week schedule was a highly active and safe regimen in patients with primary, unresectable, locally advanced NSCLC.

References

YearCitations

Page 1